Sign in

CIK 0000318154

  • Large accelerated filer
Ticker
AMGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
953540776
Phone
+1 805-447-1000
Business address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-05-19 Kullman Ellen Jamison Director Grant or award +665 14,535.98
2025-05-23 Kullman Ellen Jamison Director Grant or award +809 13,466.98
2024-05-31 Kullman Ellen Jamison Director Grant or award +719 12,299.98
2023-05-19 Kullman Ellen Jamison Director Grant or award +939 11,208.98
2022-11-08 Kullman Ellen Jamison Director Grant or award +222.31 10,112.98
2022-08-09 Kullman Ellen Jamison Director Grant or award +130.86 9,814.67
2022-05-17 Kullman Ellen Jamison Director Grant or award +855 9,607.82
2022-05-02 Kullman Ellen Jamison Director Grant or award +140.74 8,752.82
2021-11-05 Kullman Ellen Jamison Director Grant or award +152.03 8,477.08
2021-08-06 Kullman Ellen Jamison Director Grant or award +282.42 8,263.04
2021-05-18 Kullman Ellen Jamison Director Grant or award +837 7,930.62
2021-04-30 Kullman Ellen Jamison Director Grant or award +135.62 7,093.62
2021-02-05 Kullman Ellen Jamison Director Grant or award +16.93 6,908
2020-11-02 Kullman Ellen Jamison Director Grant or award +140.77 6,846.07

Page 1 of 1 · 14 trades